This PhD is embedded in the HEARTwise engineering team at TUMCREATE Singapore and is centered on the actibelt® wearable technology platform - a body-worn 3D accelerometer system with a mature clinical track record, an established algorithm library, and over 64 years of recorded patient data. The core scientific contribution expected is the development, validation, and clinical deployment of actibelt-based mobility analysis in HF patients.
The candidate will engage with open methodological questions - including how to extract richer clinical information from inertial data, how to improve reference data acquisition for algorithm development, and what mobility-based signatures may carry predictive value for HF decompensation - as well as with the translational challenge of deploying these methods in a real clinical setting.
Department: HEARTWise
Posted Date: 9 April 2026
Closing Date: Open until filled
Hours: Full Time
Duration: Fixed term contract
tum-create.edu.sg/vacancy/research-associate-phd-c...
Blueprint for regulatory acceptance of real-world walking speed (RWS) outcomes - call for focused partnerships
A new systematic review in Frontiers in Digital Health provides a clear and actionable blueprint toward regulatory acceptance of real-world walking speed (RWS) as a clinical trial outcome, particularly in diseases where the 6-minute walk test (6MWT) is already regulator-familiar (e.g., MS, neuromuscular disorders, and also cardiovascular disease).
frontiersin.org/journals/digital-health/articles/1...
The review highlights that an RWS-based endpoint (stride velocity 95th centile) has already been qualified by EMA in ambulant Duchenne muscular dystrophy, demonstrating that acceptance is achievable with a well-defined context of use and a structured evidence package. It also summarizes ongoing interactions with FDA.
In MS, long-standing trial methodology work reinforces the limitations of traditional outcomes and the need for more ecologically valid functional measures:
pubmed.ncbi.nlm.nih.gov/18480462/
pubmed.ncbi.nlm.nih.gov/19073945/
pubmed.ncbi.nlm.nih.gov/35636268/
The key message is that progress now depends on finding the right partners to collect robust datasets and document results in well-known regulatory formats. Large, complex initiatives (e.g., IMI-like structures) have often faced major operational obstacles; focused, lean consortia may be more effective.
This topic has been discussed in many previous Winter Symposia of the Human Motion Project (thehumanmotioninstitute.org) and will also be part of the upcoming symposium on March 10th:
humanmotioninstitute.de/content/event/248
See also: doi.org/10.3389/fdgth.2026.1726549
The medical devices sector is the second largest market in the world. Today’s revision
promotes competitiveness and innovation, setting one of the highest standards for medical
device regulation globally.
Moderation: H. Schäffler
08.20 Begrüßung und Einführung - F. Reister und S. Andres
08.30 CTG verstehen - Grundlagen der physiologischen CTG-Interpretation, Hypoxieformen und deren Management - A. Schmid
10.00 Plazenta-Transfer Was geht wirklich rüber? pH, BE und Laktat – aber auch Sauerstoff- und Flüssigkeitsgabe - F. Reister
10.45 STAN - Technik trifft Taktik – fetales EKG - G. Schwennicke
11.15 Jenseits der Kurven – die Sicht eines Vaters - Wenn ein Kind Schaden nimmt - J. Steinmacher und B. Steinmacher
11.35 Big Data trifft Kreißsaal - Aus vielen Mustern lernen: Big-CTG-Data-Projekt - M. Daumer
12.05 Computerisiertes CTG - Mehrwerte erkennen - S. Andres
13.20 Is this Baby Fit for Labour? - CTG as Fitness Check - T. Ghi
13.50 Nicht-hypoxische CTG-Veränderungen - Triple I und grünes Fruchtwasser - M. Bolten
15.05 Neues aus der Forschung - Der CTG Journal Club - M. Khodawandi und A. Schmid
15.35 Mythen im CTG: Was ist Fakt, was ist Fantasie? - Jitter, Doppelherz, Kindsbewegung, Wehe – Wie wird alles registriert? - A. Kinzkofer
16.05 Kasuistik - Anwendung des physiologischen CTGs anhand eines Falls - S. Andres
16.35 Ausblick und Verabschiedung - F. Reister
Wie verändern KI und digitale Technologien die medizinische Diagnostik und Versorgung? Welche Chancen ergeben sich daraus für Forschung, Entwicklung und Gesundheitswirtschaft in der Region? Diesen Fragen widmet sich die gemeinsame Veranstaltung des VDI und unseres Partners CSI am 3. Juli 2025 in München: Die Veranstaltung bringt führende Akteure aus Industrie, Forschung und Verbänden zusammen, um Innovationen in der Medizintechnik mit Schwerpunkt Künstliche Intelligenz (KI), Neurotechnologie, Simulation & Digital Twin sowie Wearables zu präsentieren und zu diskutieren. Die Teilnehmerzahl ist beschränkt. Sollte die Veranstaltung ausgebucht sein, führen wir eine Warteliste unter: bv@vdi-sued.de Anreise: ÖPNV: U4/U5 Heimeranplatz, Parken in der Tiefgarage möglich.